Breast cancer diagnosis: Imaging techniques and biochemical markers SH Jafari, Z Saadatpour, A Salmaninejad, F Momeni, M Mokhtari, ... Journal of cellular physiology 233 (7), 5200-5213, 2018 | 471 | 2018 |
MicroRNA: A novel target of curcumin in cancer therapy H Mirzaei, A Masoudifar, A Sahebkar, N Zare, J Sadri Nahand, B Rashidi, ... Journal of cellular physiology 233 (4), 3004-3015, 2018 | 256 | 2018 |
Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: a review J Sadri Nahand, M Moghoofei, A Salmaninejad, Z Bahmanpour, ... International journal of cancer 146 (2), 305-320, 2020 | 211 | 2020 |
microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer JS Nahand, S Taghizadeh‐boroujeni, M Karimzadeh, S Borran, ... Journal of cellular physiology 234 (10), 17064-17099, 2019 | 176 | 2019 |
MicroRNAs and exosomes in depression: potential diagnostic biomarkers J Tavakolizadeh, K Roshanaei, A Salmaninejad, R Yari, JS Nahand, ... Journal of Cellular Biochemistry 119 (5), 3783-3797, 2018 | 161 | 2018 |
Epi-drugs and Epi-miRs: moving beyond current cancer therapies R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ... Current cancer drug targets 16 (9), 773-788, 2016 | 136 | 2016 |
Therapeutic application of multipotent stem cells H Mirzaei, A Sahebkar, LS Sichani, A Moridikia, S Nazari, J Sadri Nahand, ... Journal of cellular physiology 233 (4), 2815-2823, 2018 | 133 | 2018 |
MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers K Golabchi, R Soleimani‐Jelodar, N Aghadoost, F Momeni, A Moridikia, ... Journal of cellular physiology 233 (4), 3016-3023, 2018 | 125 | 2018 |
Chitosan-based nanoparticles against viral infections H Boroumand, F Badie, S Mazaheri, ZS Seyedi, JS Nahand, M Nejati, ... Frontiers in Cellular and Infection Microbiology 11, 643953, 2021 | 117 | 2021 |
Boron neutron capture therapy: Moving toward targeted cancer therapy HR Mirzaei, A Sahebkar, R Salehi, JS Nahand, E Karimi, MR Jaafari, ... Journal of cancer research and therapeutics 12 (2), 520-525, 2016 | 100 | 2016 |
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC T Donyavi, F Bokharaei-Salim, HB Baghi, K Khanaliha, MA Janat-Makan, ... International immunopharmacology 97, 107641, 2021 | 98 | 2021 |
Influenza vaccine: Where are we and where do we go? M Keshavarz, H Mirzaei, M Salemi, F Momeni, MJ Mousavi, ... Reviews in medical virology 29 (1), e2014, 2019 | 90 | 2019 |
Genetic and epigenetic contribution to astrocytic gliomas pathogenesis P Khani, F Nasri, F Khani Chamani, F Saeidi, J Sadri Nahand, ... Journal of neurochemistry 148 (2), 188-203, 2019 | 90 | 2019 |
Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy? SMR Hashemian, A Sheida, M Taghizadieh, MY Memar, MR Hamblin, ... Biomedicine & Pharmacotherapy 162, 114367, 2023 | 88 | 2023 |
Exosomal microRNAs: novel players in cervical cancer JS Nahand, NR Vandchali, H Darabi, M Doroudian, HR Banafshe, ... Epigenomics 12 (18), 1651-1660, 2020 | 88 | 2020 |
MicroRNA let-7 and viral infections: focus on mechanisms of action A Letafati, S Najafi, M Mottahedi, M Karimzadeh, A Shahini, S Garousi, ... Cellular & Molecular Biology Letters 27 (1), 14, 2022 | 82 | 2022 |
MicroRNAs and exosomes: key players in HIV pathogenesis J Sadri Nahand, F Bokharaei‐Salim, M Karimzadeh, M Moghoofei, ... HIV medicine 21 (4), 246-278, 2020 | 79 | 2020 |
Exosomal miRNAs: novel players in viral infection JS Nahand, M Mahjoubin-Tehran, M Moghoofei, MH Pourhanifeh, ... Epigenomics 12 (4), 353-370, 2020 | 73 | 2020 |
Circular RNAs: new epigenetic signatures in viral infections JS Nahand, S Jamshidi, MR Hamblin, M Mahjoubin-Tehran, M Vosough, ... Frontiers in microbiology 11, 1853, 2020 | 71 | 2020 |
The role of miR‐146a in viral infection JS Nahand, MR Karimzadeh, M Nezamnia, M Fatemipour, A Khatami, ... IUBMB life 72 (3), 343-360, 2020 | 67 | 2020 |